JTC Employer Solutions Trustee’s Acadia Pharmaceuticals ACAD Stock Holding History

JTC Employer Solutions Trustee’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,200	Closed	-$69K	–	339
2023 Q4	$69K	Hold	2,200	–	–	0.01%	229
2023 Q3	$46K	Hold	2,200	–	–	﹤0.01%	258
2023 Q2	$53K	Hold	2,200	–	–	0.01%	253
2023 Q1	$41K	Hold	2,200	–	–	﹤0.01%	276
2022 Q4	$35K	Hold	2,200	–	–	﹤0.01%	294
2022 Q3	$36K	Hold	2,200	–	–	0.01%	236
2022 Q2	$31K	Hold	2,200	–	–	﹤0.01%	219
2022 Q1	$53K	Hold	2,200	–	–	0.01%	202
2021 Q4	$51K	Hold	2,200	–	–	0.01%	212
2021 Q3	$37K	Hold	2,200	–	–	0.01%	231
2021 Q2	$54K	Buy	+2,200	New	+$49.7K	0.01%	210

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JTC Employer Solutions Trustee's ACAD Position: Q1 2024 in Review

JTC Employer Solutions Trustee sold out of Acadia Pharmaceuticals (ACAD) in Q1 2024, closing a stake of 2,200 shares — an estimated $69K sold.

JTC Employer Solutions Trustee first reported a position in ACAD in Q2 2021 and held it in 11 quarters. The position peaked at $69K in Q4 2023. 267 funds tracked by Wall St. Rank hold ACAD as of Q1 2024.

JTC Employer Solutions Trustee reported no remaining Acadia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
JTC Employer Solutions Trustee sold 2,200 Acadia Pharmaceuticals shares in Q1 2024, an estimated $69K.
JTC Employer Solutions Trustee first reported a position in Acadia Pharmaceuticals in Q2 2021 and held it in 11 quarters.
JTC Employer Solutions Trustee's Acadia Pharmaceuticals position peaked at $69K in Q4 2023.
267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2024.

Based on JTC Employer Solutions Trustee's 13F filing for Q1 2024, filed 19 Apr 2024.